A, D., D, T., F, E., A, L., S, V., S, K., . . . Y, P. (2025). Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma. Cancers, 17(13), . https://doi.org/10.3390/cancers17132078
Chicago Style (17th ed.) CitationA, Dhall, et al. "Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma." Cancers 17, no. 13 (2025). https://doi.org/10.3390/cancers17132078.
MLA (9th ed.) CitationA, Dhall, et al. "Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma." Cancers, vol. 17, no. 13, 2025, https://doi.org/10.3390/cancers17132078.
Warning: These citations may not always be 100% accurate.